These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1972852)

  • 1. C3d,g in normal human epidermal basement membrane.
    Basset-Seguin N; Yancey KB
    Acta Derm Venereol; 1990; 70(3):273. PubMed ID: 1972852
    [No Abstract]   [Full Text] [Related]  

  • 2. C3d,g is present in normal human epidermal basement membrane.
    Basset-Seguin N; Dersookian M; Cehrs K; Yancey KB
    J Immunol; 1988 Aug; 141(4):1273-80. PubMed ID: 3135326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of C3d,g in normal human epidermal basement membrane.
    Yancey KB; Basset-Séguin N
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):122S-127S. PubMed ID: 2191048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3d,g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation.
    Basset-Séguin N; Porneuf M; Dereure O; Mils V; Tesnières A; Yancey KB; Guilhou JJ
    J Invest Dermatol; 1993 Dec; 101(6):827-31. PubMed ID: 8245511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective expression of basement membrane-associated C3d,g in papulonodular basal cell carcinomas.
    Basset-Séguin N; Uhle P; Emanuel D; Henry P; Yancey KB
    J Invest Dermatol; 1989 May; 92(5):734-8. PubMed ID: 2654297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast.
    Leivo I; Engvall E
    J Cell Biol; 1986 Sep; 103(3):1091-100. PubMed ID: 3488995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of C3d deposits in membranous nephropathy.
    Doi T; Kanatsu K; Nagai H; Suehiro F; Kuwahara T; Hamashima Y
    Nephron; 1984; 37(4):232-5. PubMed ID: 6379483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.
    Dauchel H; Joly P; Delpech A; Thomine E; Sauger F; Le Loet X; Lauret P; Tron F; Fontaine M; Ripoche J
    Clin Exp Immunol; 1993 May; 92(2):274-83. PubMed ID: 8485913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human cytotoxic responses by complement: C3, C3b and C3d preparations enhance human allogeneic cytotoxic responses.
    Tsokos GC; Inghirami G; Lambris JD
    J Immunopharmacol; 1986; 8(4):529-41. PubMed ID: 2949021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
    Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
    FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.
    Röther E; Lang B; Coldewey R; Hartung K; Peter HH
    Clin Rheumatol; 1993 Mar; 12(1):31-5. PubMed ID: 8467609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of C3, iC3b, and C3d in patients hospitalized for acute asthma.
    Lin RY; Caveliere LF; Lorenzana FG; Go EF; Altman KA
    Ann Allergy; 1992 Apr; 68(4):324-30. PubMed ID: 1558328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
    Freedman J; Massey A
    J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients.
    Kharazmi A; Rezai HR; Fani M; Behforouz NC
    Trans R Soc Trop Med Hyg; 1982; 76(6):793-6. PubMed ID: 6761907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for the estimation of C3d. Affinity clearance of C-determinant-bearing C3 molecules and fragments followed by estimation of C3d by ELISA.
    Asghar SS; Schraag B; Backhaus AH; Zorn I; Venneker GT; Hannema AJ
    J Immunol Methods; 1989 Jun; 120(2):207-14. PubMed ID: 2472454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
    Lachmann PJ; Voak D; Oldroyd RG; Downie DM; Bevan PC
    Vox Sang; 1983; 45(5):367-72. PubMed ID: 6605620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma.
    Seya T; Nagasawa S; Atkinson JP
    Clin Exp Immunol; 1985 Oct; 62(1):208-16. PubMed ID: 3851703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of proteins of the complement system in human skin.
    Dovezenski N; Billetta R; Gigli I
    J Clin Invest; 1992 Nov; 90(5):2000-12. PubMed ID: 1385479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.